Location History:
- Cambridge, MA (US) (2020)
- Lexington, MA (US) (2022)
Company Filing History:
Years Active: 2020-2022
Title: Girish Chopda: Innovator in Hepatocyte Research
Introduction
Girish Chopda is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for inhibiting HMGB1 expression. With a total of 2 patents, his work focuses on innovative solutions for liver-related conditions.
Latest Patents
Chopda's latest patents include compositions and methods for inhibiting HMGB1 expression. This disclosure relates to oligonucleotides, compositions, and methods useful for reducing HMGB1 expression, particularly in hepatocytes. The disclosed oligonucleotides for the reduction of HMGB1 expression may be double-stranded or single-stranded, and may be modified for improved characteristics such as stronger resistance to nucleases and lower immunogenicity. Additionally, these oligonucleotides may be designed to include targeting ligands to target specific cells or organs, such as the hepatocytes of the liver, and may be used to treat liver fibrosis and related conditions.
Career Highlights
Chopda is currently associated with Dicerna Pharmaceuticals, Inc., where he continues to advance his research in the field. His work has garnered attention for its potential impact on treating liver diseases and improving patient outcomes.
Collaborations
Some of his notable coworkers include Marc Abrams and Jihye Park, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Girish Chopda's innovative work in the field of hepatocyte research and his contributions to biotechnology highlight the importance of ongoing research in medical science. His patents reflect a commitment to developing effective treatments for liver-related conditions.